Format

Send to

Choose Destination
Int Urol Nephrol. 2017 Sep;49(9):1507-1512. doi: 10.1007/s11255-017-1625-8. Epub 2017 May 31.

Renal cell cancers: unveiling the hereditary ones and saving lives-a tailored diagnostic approach.

Author information

1
Department of Urology, Kent and Canterbury Hospital, Canterbury, UK. georgios.kallinikas@gmail.com.
2
Department of Upper G I Surgery, UCLH, London, UK.
3
Department of Urology, General Hospital of Chalkida, Chalkida, Greece.
4
Department of Urology, Konstantopouleion-Patision Hospital, Nea Ionia, Greece.
5
Department of Urology, Kent and Canterbury Hospital, Canterbury, UK.

Abstract

The prevalence of RCC in Europe is 2-3% and increasing every year. Hereditary predisposition is found in 5-8% of all RCC cases. Hereditary syndromes associated with RCC include: Von Hippel-Lindau, hereditary papillary renal cell carcinoma, Birt-Hogg-Dube', hereditary leiomyomatosis, succinate dehydrogenase's deficiency, tuberous sclerosis complex and Cowden's syndrome. These syndromes are related to specific genetic mutations. So far the European Association of Urology and American Urological Association have not established guidelines for referral of patients with RCC for germline mutation screening. The scope of this article is to review which clinical manifestations should direct clinicians' thinking towards hereditary kidney carcinomas and therefore suggest which patients could benefit from genetic testing.

KEYWORDS:

Genetic counseling; Genetic testing; Germline mutation; Kidney neoplasms; Renal cell carcinoma; Von Hippel–Lindau

PMID:
28567709
DOI:
10.1007/s11255-017-1625-8

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center